| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10309102 | Seizure | 2005 | 4 Pages |
Abstract
The use of VPA in the treatment of epilepsy is not associated with visual field defects similar to vigabatrin, but may induce abnormalities in colour vision.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Iiris Sorri, Eeva Rissanen, Maija Mäntyjärvi, Reetta Kälviäinen,